Where Nature Meets Deep-Tech

We are a team of scientists and entrepreneurs dedicated to solving the $4.2B nitrite paradox through innovative stem-cell derived antimicrobials.

Our Origin

Powered by a World‑Class Team of Scientists

HealBac is a Singapore-based biotech spin-off. Our journey began at A*STAR (Agency for Science, Technology and Research), where our founders identified a natural defense mechanism within cells that could be repurposed to protect the global food supply.

Science-First Approach

Rigorous peer-reviewed discovery engine.

Singapore Roots, Global Impact

Scaling technologies from the heart of Asia's biotech hub.

"Our mission is to eliminate carcinogenic preservatives from every dinner table, without compromising on food safety or manufacturer profits."

The HealBac Vision

2026 Strategy Roadmap

The Leadership team

Expertise spanning stem-cell innovation, microbiology, and deep-tech financial strategy.

Dr Avinanda Banerjee

Acting CEO & Business Lead

Drug discovery expert, >20 years in R&D and project management at A*STAR Skin Research Labs.

Dr Smarajit Chakraborty

Scientific Lead

Microbiologist turned stem-cell innovator, >15 years in antimicrobial and peptide research at SIFBI, A*STAR.

Dr Shigeki Sugii

Operations Lead

Principal Scientist at A*STAR, built multiple deep-tech ventures from scratch, guiding strategic planning.

Ganesh Kannan

Regulatory Lead & QA

Focused on process scale-up, regulatory dossiers, and coordination with global manufacturing partners.